Default contrast Cream and blue contrast Black and yellow contrast Blue and dark blue contrast
Home > Patient > Cancer Patient Information

Latest Events

View all latest events

Submit your feedback about the cancer information pathways

Your feedback will help improve the patient information leaflets provided freely to cancer patients and their carers. Click here to submit your feedback to the NCAT Patient Experience team.

Cancer Patient Information

NCAT are pleased to provide a range of comprehensive and up to date cancer patient information from a wide range of cancer charities including Macmillan Cancer Support , Cancer Research UK , the Prostate Cancer Charity, Breast Cancer Care and Breakthrough Breast Cancer. This information has been approved by NHS clinicians and patients on behalf of the National Cancer Action Team for inclusion into the National cancer patient information pathways . There are currently 44 national cancer patient information pathways providing high quality patient information to support cancer patients and those affected by cancer covering the following areas.

Click to access the full range of leaflets.

  • AA-LOCAL CONTENT-by cancer pathway
  • AA-LOCAL CONTENT-Cancer Information & Support Centres A-L
  • AA-LOCAL CONTENT-Cancer Information & Support Centres L-R
  • AA-LOCAL CONTENT-Cancer Information & Support Centres S-Z
  • AA-LOCAL CONTENT-CANCER NETWORKS
  • AA-LOCAL CONTENT-NHS A-K
  • AA-LOCAL CONTENT-NHS L-R
  • AA-LOCAL CONTENT-NHS S-Z
  • Acute Lymphoblastic Leukaemia
  • Acute Myeloid Leukemia
  • Advanced cancer and Palliative care
  • Anal cancer
  • Bile Duct
  • Biological Therapies
  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Cancer in Children and Young People-general information
  • Cancer in Children and Young People: Cancer Types
  • Cancer Rehabilitation and living with cancer
  • Cervical cancer
  • Chemotherapy & Treatments Pathway
  • Children and Young People-End of life and bereavement
  • Chronic Lymphocytic Leukaemia
  • Chronic Myeloid Leukaemia
  • DRAFT Bone Sarcoma-National Specialised Commissioning Team
  • DRAFT- Cancer of the ureter
  • DRAFT-Adrenal gland tumours
  • DRAFT-Anorectal melanoma
  • DRAFT-Breast cancer in men
  • DRAFT-Cancer of the thymus
  • DRAFT-Choriocarcinoma-National Specialised Commissioning Team
  • DRAFT-Kaposi's Sarcoma
  • DRAFT-KINGS COLLEGE-Myelodysplastic syndromes and myeloproliferative neoplasms
  • DRAFT-KINGS COLLEGE-Myeloproliferative disorders
  • DRAFT-KINGS COLLEGE-Neuroendocrine Tumours (NETs)
  • DRAFT-KINGS COLLEGE-Neuroendocrine-carcinoid
  • DRAFT-KINGS COLLEGE-Neuroendocrine-Gastroenteropancreatic tumours (GEPs)
  • DRAFT-KINGS-Bone Marrow Transplant
  • DRAFT-Multiple endocrine neoplasia
  • DRAFT-Ocular oncology-National Specialised Commissioning Team
  • DRAFT-Parathyroid gland tumours
  • DRAFT-Pituitory disorders and tumours
  • DRAFT-Primary peritoneal cancer
  • DRAFT-Pseudomyxoma peritonei-National Specialised Commissioning Team
  • DRAFT-Retinoblastoma-National Specialised Commissioning Team
  • DRAFT-Tonsil cancer
  • End of life and bereavement
  • Eye cancer
  • Gallbladder
  • Hairy Cell Leukaemia
  • Head and Neck: Other cancers and general information
  • Hodgkin's lymphoma
  • Kidney cancer
  • Larynx (Laryngeal cancer)
  • Liver cancer
  • Living with Cancer - work and finance
  • Lung cancer
  • Melanoma
  • Mesothelioma
  • Molar pregnancy
  • Mouth cancer
  • Myeloma
  • Nasal and sinus cancer
  • Nasopharynx (Nasopharyngeal cancer)
  • Non-Hodgkin's lymphoma
  • Non-melanoma
  • Oesophageal cancer
  • Ovarian cancer
  • OXFORD DRAFT-Bone Sarcoma
  • OXFORD-Testicular
  • Pancreatic cancer
  • Penis
  • Persistent trophoblastic disease
  • Prostate cancer
  • Radiotherapy
  • ROYAL COLLEGES & CANCER SCREENING
  • Salivary gland cancer
  • Soft tissue sarcoma
  • Stomach cancer
  • Testis
  • Thyroid cancer
  • Unknown Primary Cancer
  • Vaginal cancer
  • Vulval cancer
  • Womb cancer